Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3
Resveratrol (RES) has a protective effect on osteoarthritis (OA), nevertheless, the underlying mechanisms of RES towards obesity-related OA are still unclear. This study is aimed to determine whether leptin resistant mechanism presents in articular cartilage of obesity-related OA and whether the pro...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 2020-02, Vol.388, p.114871, Article 114871 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 114871 |
container_title | Toxicology and applied pharmacology |
container_volume | 388 |
creator | Jiang, Mengqi He, Jianyi Gu, Hailun Yang, Yingchun Huang, Yue Xu, Xiaolei Liu, Li |
description | Resveratrol (RES) has a protective effect on osteoarthritis (OA), nevertheless, the underlying mechanisms of RES towards obesity-related OA are still unclear. This study is aimed to determine whether leptin resistant mechanism presents in articular cartilage of obesity-related OA and whether the protective effect of RES is involved in the regulation of leptin signal by affecting suppressor of cytokine signaling 3 (SOCS3). Male C57BL/6 J mice were fed with standard chow diet, high fat diet (HFD) or high fat diet with RES (45 mg/kg.bw) for 22 weeks. Knee joints of mice were evaluated by histological and immunohistochemistry analysis. Serum level of leptin was measured by ELISA. The leptin, leptin receptor (OB-Rb), SOCS3 mRNA expression and JAK2, STAT3, OB-Rb and SOCS3 protein expression in cartilage were determined by real-time RT-PCR and western blot. In addition, SW1353 cells were pretreated with or without AG490, and stimulated with leptin in the presence or absence of RES to detect JAK2, STAT3, matrix metalloproteinase-13 (MMP-13) and SOCS3 expression. We found that HFD could induce obesity-related OA and RES prevented its progression. Serum leptin and mRNA expression in cartilage was up-regulated by HFD, while RES ameliorated the elevation. Besides, RES significantly inhibited the JAK2/STAT3 signaling pathway in cartilage, as well as SOCS3. In in vitro study, RES exhibited the same effect in SW1353 cells which stimulated with leptin. In conclusion, no significant leptin resistance existed in cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.
•Resveratrol prevented the development of obesity-related OA.•No significant leptin resistance existed in articular cartilage of obesity-related OA.•The inhibitory effect of resveratrol on obesity-related OA is independent of SOCS3. |
doi_str_mv | 10.1016/j.taap.2019.114871 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_31881177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X1930479X</els_id><sourcerecordid>31881177</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-9c21ddbd6e0fde3d803859184d89197cf53edd9b9ee3b4e4ac62ca965059ce7d3</originalsourceid><addsrcrecordid>eNp9kNtKAzEQhoMoWg8v4IXkBbbNbPYU8KYUz4JCK3gXssmspqybJYmVPoGv7daql97MPwz_PzN8hJwCGwODYrIcR6X6ccpAjAGyqoQdMgImioRxznfJiLEMEsaq5wNyGMKSMSayDPbJAYeqAijLEfl89C6ijnaFFJtm6KhrqMewQq-idy11HXU1BhvXicdWRTTUhYhO-fjqbbSBrqyiqm1x0Gi7F3o7vUsn88V0wWmwL51qN8NexdcPtaaD33YGexxK931s_jCb82Oy16g24MmPHpGny4vF7Dq5f7i6mU3vE83zIiZCp2BMbQpkjUFuKsarXECVmUqAKHWTczRG1AKR1xlmShepVqLIWS40loYfkXS7V3sXgsdG9t6-Kb-WwOSGqlzKDVW5oSq3VIfQ2TbUv9dvaP4ivxgHw_nWgMPrK4teBm2x02isH5BK4-x_-78A0jyLrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3</title><source>Elsevier ScienceDirect Journals</source><creator>Jiang, Mengqi ; He, Jianyi ; Gu, Hailun ; Yang, Yingchun ; Huang, Yue ; Xu, Xiaolei ; Liu, Li</creator><creatorcontrib>Jiang, Mengqi ; He, Jianyi ; Gu, Hailun ; Yang, Yingchun ; Huang, Yue ; Xu, Xiaolei ; Liu, Li</creatorcontrib><description>Resveratrol (RES) has a protective effect on osteoarthritis (OA), nevertheless, the underlying mechanisms of RES towards obesity-related OA are still unclear. This study is aimed to determine whether leptin resistant mechanism presents in articular cartilage of obesity-related OA and whether the protective effect of RES is involved in the regulation of leptin signal by affecting suppressor of cytokine signaling 3 (SOCS3). Male C57BL/6 J mice were fed with standard chow diet, high fat diet (HFD) or high fat diet with RES (45 mg/kg.bw) for 22 weeks. Knee joints of mice were evaluated by histological and immunohistochemistry analysis. Serum level of leptin was measured by ELISA. The leptin, leptin receptor (OB-Rb), SOCS3 mRNA expression and JAK2, STAT3, OB-Rb and SOCS3 protein expression in cartilage were determined by real-time RT-PCR and western blot. In addition, SW1353 cells were pretreated with or without AG490, and stimulated with leptin in the presence or absence of RES to detect JAK2, STAT3, matrix metalloproteinase-13 (MMP-13) and SOCS3 expression. We found that HFD could induce obesity-related OA and RES prevented its progression. Serum leptin and mRNA expression in cartilage was up-regulated by HFD, while RES ameliorated the elevation. Besides, RES significantly inhibited the JAK2/STAT3 signaling pathway in cartilage, as well as SOCS3. In in vitro study, RES exhibited the same effect in SW1353 cells which stimulated with leptin. In conclusion, no significant leptin resistance existed in cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.
•Resveratrol prevented the development of obesity-related OA.•No significant leptin resistance existed in articular cartilage of obesity-related OA.•The inhibitory effect of resveratrol on obesity-related OA is independent of SOCS3.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2019.114871</identifier><identifier>PMID: 31881177</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Leptin ; Obesity ; Osteoarthritis ; Resveratrol ; SOCS3</subject><ispartof>Toxicology and applied pharmacology, 2020-02, Vol.388, p.114871, Article 114871</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-9c21ddbd6e0fde3d803859184d89197cf53edd9b9ee3b4e4ac62ca965059ce7d3</citedby><cites>FETCH-LOGICAL-c356t-9c21ddbd6e0fde3d803859184d89197cf53edd9b9ee3b4e4ac62ca965059ce7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.taap.2019.114871$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31881177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiang, Mengqi</creatorcontrib><creatorcontrib>He, Jianyi</creatorcontrib><creatorcontrib>Gu, Hailun</creatorcontrib><creatorcontrib>Yang, Yingchun</creatorcontrib><creatorcontrib>Huang, Yue</creatorcontrib><creatorcontrib>Xu, Xiaolei</creatorcontrib><creatorcontrib>Liu, Li</creatorcontrib><title>Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Resveratrol (RES) has a protective effect on osteoarthritis (OA), nevertheless, the underlying mechanisms of RES towards obesity-related OA are still unclear. This study is aimed to determine whether leptin resistant mechanism presents in articular cartilage of obesity-related OA and whether the protective effect of RES is involved in the regulation of leptin signal by affecting suppressor of cytokine signaling 3 (SOCS3). Male C57BL/6 J mice were fed with standard chow diet, high fat diet (HFD) or high fat diet with RES (45 mg/kg.bw) for 22 weeks. Knee joints of mice were evaluated by histological and immunohistochemistry analysis. Serum level of leptin was measured by ELISA. The leptin, leptin receptor (OB-Rb), SOCS3 mRNA expression and JAK2, STAT3, OB-Rb and SOCS3 protein expression in cartilage were determined by real-time RT-PCR and western blot. In addition, SW1353 cells were pretreated with or without AG490, and stimulated with leptin in the presence or absence of RES to detect JAK2, STAT3, matrix metalloproteinase-13 (MMP-13) and SOCS3 expression. We found that HFD could induce obesity-related OA and RES prevented its progression. Serum leptin and mRNA expression in cartilage was up-regulated by HFD, while RES ameliorated the elevation. Besides, RES significantly inhibited the JAK2/STAT3 signaling pathway in cartilage, as well as SOCS3. In in vitro study, RES exhibited the same effect in SW1353 cells which stimulated with leptin. In conclusion, no significant leptin resistance existed in cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.
•Resveratrol prevented the development of obesity-related OA.•No significant leptin resistance existed in articular cartilage of obesity-related OA.•The inhibitory effect of resveratrol on obesity-related OA is independent of SOCS3.</description><subject>Leptin</subject><subject>Obesity</subject><subject>Osteoarthritis</subject><subject>Resveratrol</subject><subject>SOCS3</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kNtKAzEQhoMoWg8v4IXkBbbNbPYU8KYUz4JCK3gXssmspqybJYmVPoGv7daql97MPwz_PzN8hJwCGwODYrIcR6X6ccpAjAGyqoQdMgImioRxznfJiLEMEsaq5wNyGMKSMSayDPbJAYeqAijLEfl89C6ijnaFFJtm6KhrqMewQq-idy11HXU1BhvXicdWRTTUhYhO-fjqbbSBrqyiqm1x0Gi7F3o7vUsn88V0wWmwL51qN8NexdcPtaaD33YGexxK931s_jCb82Oy16g24MmPHpGny4vF7Dq5f7i6mU3vE83zIiZCp2BMbQpkjUFuKsarXECVmUqAKHWTczRG1AKR1xlmShepVqLIWS40loYfkXS7V3sXgsdG9t6-Kb-WwOSGqlzKDVW5oSq3VIfQ2TbUv9dvaP4ivxgHw_nWgMPrK4teBm2x02isH5BK4-x_-78A0jyLrg</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Jiang, Mengqi</creator><creator>He, Jianyi</creator><creator>Gu, Hailun</creator><creator>Yang, Yingchun</creator><creator>Huang, Yue</creator><creator>Xu, Xiaolei</creator><creator>Liu, Li</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200201</creationdate><title>Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3</title><author>Jiang, Mengqi ; He, Jianyi ; Gu, Hailun ; Yang, Yingchun ; Huang, Yue ; Xu, Xiaolei ; Liu, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-9c21ddbd6e0fde3d803859184d89197cf53edd9b9ee3b4e4ac62ca965059ce7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Leptin</topic><topic>Obesity</topic><topic>Osteoarthritis</topic><topic>Resveratrol</topic><topic>SOCS3</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Mengqi</creatorcontrib><creatorcontrib>He, Jianyi</creatorcontrib><creatorcontrib>Gu, Hailun</creatorcontrib><creatorcontrib>Yang, Yingchun</creatorcontrib><creatorcontrib>Huang, Yue</creatorcontrib><creatorcontrib>Xu, Xiaolei</creatorcontrib><creatorcontrib>Liu, Li</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Mengqi</au><au>He, Jianyi</au><au>Gu, Hailun</au><au>Yang, Yingchun</au><au>Huang, Yue</au><au>Xu, Xiaolei</au><au>Liu, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>388</volume><spage>114871</spage><pages>114871-</pages><artnum>114871</artnum><issn>0041-008X</issn><eissn>1096-0333</eissn><abstract>Resveratrol (RES) has a protective effect on osteoarthritis (OA), nevertheless, the underlying mechanisms of RES towards obesity-related OA are still unclear. This study is aimed to determine whether leptin resistant mechanism presents in articular cartilage of obesity-related OA and whether the protective effect of RES is involved in the regulation of leptin signal by affecting suppressor of cytokine signaling 3 (SOCS3). Male C57BL/6 J mice were fed with standard chow diet, high fat diet (HFD) or high fat diet with RES (45 mg/kg.bw) for 22 weeks. Knee joints of mice were evaluated by histological and immunohistochemistry analysis. Serum level of leptin was measured by ELISA. The leptin, leptin receptor (OB-Rb), SOCS3 mRNA expression and JAK2, STAT3, OB-Rb and SOCS3 protein expression in cartilage were determined by real-time RT-PCR and western blot. In addition, SW1353 cells were pretreated with or without AG490, and stimulated with leptin in the presence or absence of RES to detect JAK2, STAT3, matrix metalloproteinase-13 (MMP-13) and SOCS3 expression. We found that HFD could induce obesity-related OA and RES prevented its progression. Serum leptin and mRNA expression in cartilage was up-regulated by HFD, while RES ameliorated the elevation. Besides, RES significantly inhibited the JAK2/STAT3 signaling pathway in cartilage, as well as SOCS3. In in vitro study, RES exhibited the same effect in SW1353 cells which stimulated with leptin. In conclusion, no significant leptin resistance existed in cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.
•Resveratrol prevented the development of obesity-related OA.•No significant leptin resistance existed in articular cartilage of obesity-related OA.•The inhibitory effect of resveratrol on obesity-related OA is independent of SOCS3.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31881177</pmid><doi>10.1016/j.taap.2019.114871</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 2020-02, Vol.388, p.114871, Article 114871 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_pubmed_primary_31881177 |
source | Elsevier ScienceDirect Journals |
subjects | Leptin Obesity Osteoarthritis Resveratrol SOCS3 |
title | Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A25%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20effect%20of%20resveratrol%20on%20obesity-related%20osteoarthritis%20via%20alleviating%20JAK2/STAT3%20signaling%20pathway%20is%20independent%20of%20SOCS3&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Jiang,%20Mengqi&rft.date=2020-02-01&rft.volume=388&rft.spage=114871&rft.pages=114871-&rft.artnum=114871&rft.issn=0041-008X&rft.eissn=1096-0333&rft_id=info:doi/10.1016/j.taap.2019.114871&rft_dat=%3Cpubmed_cross%3E31881177%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31881177&rft_els_id=S0041008X1930479X&rfr_iscdi=true |